Certified by Founder Lodge
Aspect Biosystems
Canada - Vancouver, BC
START UP
1 Disclosed Funding Rounds $115,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Aspect’s bioprinted tiss
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 09 ,2025 | Series B | $115,000,000 |
Radical Ventures
Pangaea Ventures
Dimension
Pallasite Ventures Inc.
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
AIRRIVED | $6,100,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
